US2020276401A1PendingUtilityA1

Nasal administration

Assignee: OPTINOSE ASPriority: Jan 19, 2006Filed: Sep 26, 2019Published: Sep 3, 2020
Est. expiryJan 19, 2026(expired)· nominal 20-yr term from priority
A61M 15/0065A61M 11/00A61M 2202/04A61M 15/009A61M 2202/064H01M 4/9066A61M 15/08H01M 4/861H01M 8/0247A61K 31/404H01M 8/023H01M 4/8642H01M 2008/1293A61M 16/0493Y02E60/50H01M 2004/8684A61M 15/0021H01M 4/8657A61M 15/0098A61M 16/20A61M 16/049A61M 15/0091
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A delivery device for and method of providing for delivery of substance to the central nervous system (CNS) of a subject, the delivery device comprising: a nosepiece unit (17) for insertion into a nasal airway (1) of a subject and comprising an outlet unit (21) which includes a nozzle (25) for delivering substance into the nasal airway of the subject; and a substance supply unit which is operable to deliver a dose of substance to the nozzle: wherein the delivery device is configured such that at least 30% of the dose as initially deposited in the nasal airway is deposited in an upper posterior region of the nasal airway, thereby providing a CNS concentration of the substance, and hence CNS effect, which is significantly greater than that which would be predicted from a counterpart blood plasma concentration of the substance.

Claims

exact text as granted — not AI-modified
1 - 85 . (canceled) 
     
     
         86 . A liquid substance delivery device, comprising:
 a housing;   a nosepiece attached to the housing via a snap-fit connection, the nosepiece including an outlet and a cuff member, the cuff member configured to block a nasal valve of a subject when at least a portion of the nosepiece is fitted in a nasal passage of the subject;   a mouthpiece attached to the housing and comprising an inlet, the inlet of the mouthpiece being fluidly connected via the housing to the outlet of the nosepiece;   a liquid delivery pump configured to expel a metered amount of pharmaceutical substance through the outlet of the nosepiece upon actuation of the pump;   a gas supply unit configured to deliver an amount of gas through the outlet of the nosepiece, the delivered gas being a pharmaceutically acceptable gas other than an exhaled air flow;   wherein the liquid delivery pump contains a plurality of metered amounts of the pharmaceutical substance.

Join the waitlist — get patent alerts

Track US2020276401A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.